ROSCIGNO, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 5.540
AS - Asia 2.764
EU - Europa 2.507
Continente sconosciuto - Info sul continente non disponibili 898
SA - Sud America 480
AF - Africa 65
OC - Oceania 6
Totale 12.260
Nazione #
US - Stati Uniti d'America 5.176
IT - Italia 1.518
SG - Singapore 968
CN - Cina 459
HK - Hong Kong 401
VN - Vietnam 385
BR - Brasile 371
RU - Federazione Russa 316
CA - Canada 264
BD - Bangladesh 188
DE - Germania 109
SE - Svezia 103
IE - Irlanda 100
FR - Francia 90
IN - India 80
GB - Regno Unito 62
KR - Corea 43
AR - Argentina 42
MX - Messico 41
UA - Ucraina 32
NL - Olanda 31
ES - Italia 29
IQ - Iraq 29
ID - Indonesia 28
FI - Finlandia 27
TR - Turchia 25
PK - Pakistan 23
SA - Arabia Saudita 21
ZA - Sudafrica 21
AT - Austria 19
PL - Polonia 18
EC - Ecuador 17
VE - Venezuela 17
JM - Giamaica 15
JP - Giappone 14
PH - Filippine 13
CR - Costa Rica 12
GT - Guatemala 10
CO - Colombia 9
JO - Giordania 8
MY - Malesia 8
CL - Cile 7
DK - Danimarca 7
MA - Marocco 7
PY - Paraguay 6
RO - Romania 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
AU - Australia 5
AZ - Azerbaigian 5
BG - Bulgaria 5
EG - Egitto 5
IL - Israele 5
KH - Cambogia 5
PS - Palestinian Territory 5
TH - Thailandia 5
TN - Tunisia 5
AM - Armenia 4
CH - Svizzera 4
DZ - Algeria 4
ET - Etiopia 4
LA - Repubblica Popolare Democratica del Laos 4
LT - Lituania 4
NP - Nepal 4
PE - Perù 4
PR - Porto Rico 4
SN - Senegal 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
BO - Bolivia 3
CZ - Repubblica Ceca 3
HN - Honduras 3
KZ - Kazakistan 3
LV - Lettonia 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BE - Belgio 2
DO - Repubblica Dominicana 2
GR - Grecia 2
IR - Iran 2
KE - Kenya 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LY - Libia 2
MN - Mongolia 2
MU - Mauritius 2
NG - Nigeria 2
PA - Panama 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
GE - Georgia 1
GP - Guadalupe 1
HT - Haiti 1
Totale 11.347
Città #
Ashburn 727
Milan 681
Singapore 558
Ann Arbor 398
Hong Kong 381
San Jose 301
Fairfield 198
Toronto 188
Rome 174
Houston 169
Los Angeles 137
Chandler 136
New York 122
Woodbridge 119
Seattle 108
Wilmington 105
Dallas 101
Hefei 101
Ho Chi Minh City 101
Beijing 100
Dublin 97
Chicago 94
Santa Clara 90
Hanoi 88
Princeton 66
Cambridge 63
The Dalles 60
Miano 56
Figino 51
Buffalo 50
Lauterbourg 48
Jacksonville 45
Council Bluffs 43
Seoul 43
São Paulo 42
Turin 38
Munich 36
Lawrence 33
Frankfurt am Main 32
Dong Ket 29
Moscow 29
Newark 29
Altamura 28
Ottawa 27
Brooklyn 26
Nuremberg 24
Philadelphia 21
San Diego 21
Montreal 20
Phoenix 20
Washington 20
Boardman 19
Memphis 19
Naples 19
Orem 19
Florence 18
Atlanta 17
Denver 17
Haiphong 17
Charlotte 16
London 16
Mexico City 16
Warsaw 16
Jakarta 15
Da Nang 14
Porto Alegre 14
Andover 13
Brasília 13
Miami 13
San Francisco 13
Turku 13
Baghdad 12
Boston 12
Brescia 12
Columbus 11
Johannesburg 11
Salt Lake City 11
Shenyang 11
Spirano 11
Bari 10
Elk Grove Village 10
Guangzhou 10
Las Vegas 10
Mumbai 10
Palermo 10
Riyadh 10
Tokyo 10
Bologna 9
Lahore 9
Poplar 9
Queens 9
Treviolo 9
Amman 8
Amsterdam 8
Ankara 8
Chennai 8
Curitiba 8
Dearborn 8
Guatemala City 8
Nanjing 8
Totale 6.871
Nome #
Nomogram for predicting the likelihood of postoperative surgical complications in patients treated with partial nephrectomy: a prospective multicentre observational study (the RECORd 2 project) 359
Diagnostic accuracy of multiparametric magnetic resonance imaging combined with clinical parameters in the detection of clinically significant prostate cancer: A novel diagnostic model 313
Radiomics in PI-RADS 3 Multiparametric MRI for Prostate Cancer Identification: Literature Models Re-Implementation and Proposal of a Clinical–Radiological Model 294
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study) 288
Towards the Definition of Radiomic Features and Clinical Indices to Enhance the Diagnosis of Clinically Significant Cancers in PI-RADS 4 and 5 Lesions 269
Detection of Lymph-Node Metastases with Integrated [11C]Choline PET/CT in Patients with PSA Failure after Radical Retropubic Prostatectomy: Results Confirmed by Open Pelvic-Retroperitoneal Lymphadenectomy 227
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 219
The impact of histological variants on outcomes after open radical cystectomy for muscle-invasive urothelial bladder cancer: results from a single tertiary referral centre 213
Oncologic Outcomes of Incidental Versus Biopsy-diagnosed Grade Group 1 Prostate Cancer: A Multi-institutional Study 212
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 211
Health-related quality of life 24 months after prostate cancer diagnosis: An update from the Pros-IT CNR prospective observational study 208
Extended pelvic lymph node dissection during radical prostatectomy: Comparison between initial robotic experience of a high-volume open surgeon and his contemporary open series 207
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 205
Perioperative and Mid-term Oncological and Functional Outcomes After Partial Nephrectomy for Complex (PADUA Score ≥10) Renal Tumors: A Prospective Multicenter Observational Study (the RECORD2 Project) 196
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 196
Recurrent retroperitoneal solitary fibrous tumor: a case report 192
Oncological outcomes of concomitant carcinoma in situ at radical cystectomy in pure urothelial bladder cancer and in histological variants 186
A reappraisal of the role of vesicourethral anastomosis biopsy in patient candidates for salvage radiation therapy after radical prostatectomy 183
Diagnosis of local recurrence after radical prostatectomy 180
Microsurgical Testicular Sperm Extraction: Predictive Factors and Outcomes for Men with Nonobstructive Azoospermia 180
Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy? 178
The Accuracy of Transurethral Bladder Resection in Detecting Bladder Cancer Histological Variants and Their Prognostic Value at Radical Cystectomy 177
Medium-term follow up of active surveillance for early prostate cancer at a non-academic institution 176
Difference in Frequency and Distribution of Nodal Metastases Between Intermediate and High Risk Prostate Cancer Patients: Results of a Superextended Pelvic Lymph Node Dissection 171
Applicability of COVID-19 Pandemic Recommendations for Urology Practice: Data from Three Major Italian Hot Spots (BreBeMi) 168
Renal Sinus Fat Invasion in pT3a Clear Cell Renal Cell Carcinoma Affects Outcomes of Patients Without Nodal Involvement or Distant Metastases 168
A Nomogram for the Prediction of Intermediate Significant Renal Function Loss After Robot-assisted Partial Nephrectomy for Localized Renal Tumors: A Prospective Multicenter Observational Study (RECORd2 Project) 162
Conventional testicular sperm extraction (TESE) and non-obstructive azoospermia: Is there still a chance in the era of microdissection TESE? Results from a single non-academic community hospital 158
Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract 156
Transperitoneal vs retroperitoneal minimally invasive partial nephrectomy: comparison of perioperative outcomes and functional follow-up in a large multi-institutional cohort (The RECORD 2 Project) 153
Nerve and seminal sparing radical cystectomy with orthotopic urinary diversion for select patients with superficial bladder cancer: an innovative surgical approach 152
Prediction of significant renal function decline after open, laparoscopic, and robotic partial nephrectomy: External validation of the Martini’s nomogram on the RECORD2 project cohort 151
The Use of Multiparametric Magnetic Resonance Imaging for Follow-up of Patients Included in Active Surveillance Protocol. Can PSA Density Discriminate Patients at Different Risk of Reclassification? 150
Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma 147
Multiple vesico-urethral biopsies following radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage 143
Diagnosis of isolated high-grade prostatic intra-epithelial neoplasia: proposal of a nomogram for the prediction of cancer detection at saturation re-biopsy 142
A Snapshot from the Department of Urology in Bergamo Evaluating the Timeline of the SARS-CoV-2 Outbreak: Which Patients Are We Missing? 141
Predictive accuracy of nephrometric scores can be improved by adding clinical patient characteristics: a novel algorithm combining anatomic tumour complexity, body mass index, and Charlson comorbidity index to depict perioperative complications after nephron-sparing surgery 137
Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients 134
Pros-IT CNR: an Italian prostate cancer monitoring project 134
Predicting positive surgical margins in partial nephrectomy: A prospective multicentre observational study (the RECORd 2 project) 133
Role of postoperative radiotherapy after pelvic lymphadenectomy and radical retropubic prostatectomy: a single institute experience of 415 patients 132
Complications and Other Surgical Outcomes Associated with Extended Pelvic Lymphadenectomy in Men with Localized Prostate Cancer 130
Thermo-chemotherapy and electromotive drug administration of mitomycin C in superficial bladder cancer eradication. a pilot study on marker lesion 129
Multiparametric magnetic resonance imaging and clinical variables: Which is the best combination to predict reclassification in active surveillance patients? 127
Radical nephrocapsulectomy and caval thrombectomy with extracorporeal circulation and deep hypothermic circulatory arrest in right anterior minithoracotomy: a minimally invasive approach 126
Tumour thrombus consistency: a new tool to stage patients with pT3 renal cell carcinoma (RCC) with venous tumour thrombus? 118
Diagnosis of high-grade prostatic intraepithelial neoplasia: the impact of the number of biopsy cores at initial sampling on cancer detection after a saturation re-biopsy 116
Medical therapy of prostate cancer. A review 116
The role of transrectal ultrasound of the prostatic fossa in the diagnosis of local recurrence after radical prostatectomy in case of PSA failure 112
Diagnostic value of ultrasound-guided anastomotic biopsies in patients with high PSA (> or = 0,4 ng/ml) after radical prostatectomy 112
Could 68Ga-PSMA PET/CT Evaluation Reduce the Number of Scheduled Prostate Biopsies in Men Enrolled in Active Surveillance Protocols? 94
Assessment of volume preservation performed before or after partial nephrectomy accurately predicts postoperative renal function: Results from a prospective multicenter study 59
Comparison of micro-ultrasound and multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer: a single-center experience 32
Joint survey by AIMN, AIOM, AIRO, SIU, SIUrO, and Meet-URO about the use of PSMA PET imaging in prostate cancer in Italy: PSA persistence, biochemical recurrence, hormone-sensitive and castration-resistant metastatic settings 31
Impact of Resection Technique on Perioperative Outcomes and Surgical Margins after Partial Nephrectomy for Localized Renal Masses: A Prospective Multicenter Study 30
THE OPTIMAL SAMPLING SCHEME FOR INITIAL PROSTATE BIOPSY VARIES ACCORDING TO THE CLINICAL CHARACTERISTICS OF EACH PATIENT 26
Surgical Experience and Functional Outcomes after Laparoscopic and Robot-Assisted Partial Nephrectomy: Results from a Multi-Institutional Collaboration 25
Prognostic Value of Extranodal Extension and Other Lymph Node Parameters in Patients With Upper Tract Urothelial Carcinoma 24
PSMA PET/CT in the diagnosis of prostate cancer: Why and when? 24
Initial Extended Transrectal Prostate Biopsy-Are More Prostate Cancers Detected With 18 Cores Than With 12 Cores? 23
Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy 23
Retroperitoneoscopic single-site 3D adrenalectomy for left adrenal renal cell carcinoma metastasis 20 years after left laparotomic radical nephrectomy 22
Predictors of Positive Surgical Margins after Robot-Assisted Partial Nephrectomy for Localized Renal Tumors: Insights from a Large Multicenter International Prospective Observational Project (The Surface-Intermediate-Base Margin Score Consortium) 22
THE NUMBER OF ORGANS AFFECTED BY METASTASES IS ONE OF THE MOST INFORMATIVE PREDICTOR OF RENAL CELL CARCINOMA SPECIFIC SURVIVAL IN CANDIDATES TO CYTOREDUCTIVE NEPHRECTOMY 21
Adjuvant chemotherapy for high-risk upper tract urothelial carcinoma: Results from the Upper Tract Urothelial Carcinoma Collaboration 21
Isolated ureteral malakoplakia: A conservative endoscopic approach with a strict follow-up 21
Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC) 21
Staging lymphadenectomy in renal cell carcinoma must be extended: a sensitivity curve analysis 20
Prostatic Carcinoma and Transrectal Ultrasound 20
Topical prilocaine-lidocaine cream combined with peripheral nerve block improves pain control in prostatic biopsy: Results from a prospective randomized trial 20
Increased Use of Blood Transfusions to Manage Urological Conditions during the COVID-19 Pandemic 20
DEVELOPMENT AND INTERNAL VALIDATION OF A NOMOGRAM TO DETERMINE THE IMPACT OF THE BIOPSY SCHEME ON CANCER DETECTION IN MEN UNDERGOING AN INITIAL PROSTATE BIOPSY 20
Prognostic significance of BAP1 expression in high-grade upper tract urothelial carcinoma: a multi-institutional study 19
The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy 19
Herniation of the amniotic sac into the bladder through a vesico-uterine fistula in the 32nd week of pregnancy 19
Different survival in pT3a renal cell carcinoma with sinus fat invasion or perinephric fat invasion 19
Initial extended transrectal prostatic biopsy: Do 18 cores detect more prostatic cancers than 12 cores? 19
Sezione X: derivazione urinaria; Capitoli 76 - 83 19
Tumor architecture is an independent prognostic factor for disease relapse and cancer-specific survival in patients treated with nephroureterectomy: A multi-institutional analysis of 1363 patients from the upper tract urothelial carcinoma collaboration 19
Postoperative Nomogram for Relapse-Free Survival in Patients with High Grade Upper Tract Urothelial Carcinoma 18
European temporal trends in the use of lymph node dissection in patients with renal cancer 18
Locally advanced (pT3-pT4) renal cell carcinoma: Comparison of different PT proposal of reclassification 18
The Impact of Tumor Multifocality on Outcomes in Patients Treated With Radical Nephroureterectomy 18
Prostatic Carcinoma 18
The Extent of Lymphadenectomy Seems to Be Associated with Better Survival in Patients with Nonmetastatic Upper-Tract Urothelial Carcinoma: How Many Lymph Nodes Should Be Removed? 18
Evidence-based Sex-related Outcomes After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: Results of Large Multicenter Study 18
PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomy 18
Altered Expression of the Transcription Factor Forkhead Box A1 (FOXA1) Is Associated With Poor Prognosis in Urothelial Carcinoma of the Upper Urinary Tract 18
Lymphadenectomy at the Time of Nephroureterectomy for Upper Tract Urothelial Cancer 18
PERCENTAGE OF POSITIVE CORES STRONGLY INFLUENCES THE RATE OF GLEASON SUM AGREEMENT BETWEEN PROSTATE BIOPSY AND RADICAL PROSTATECTOMY 18
Joint survey by AIMN, AIOM, AIRO, SIU, SIUrO, and Meet-URO about the use of PSMA PET imaging in prostate cancer in Italy: technical aspects and primary staging setting 18
Prognostic role of tumour multifocality in renal cell carcinoma 18
Robot-assisted partial nephrectomy in patients with recurrent disease: fiction or fact? 18
PREDICTIVE FACTORS OF RESECTION TECHNIQUES DURING PARTIAL NEPHRECTOMY IN A COHORT OF "ENUCLEORESECTIVE" CENTERS: INSIGHTS FROM THE SURFACE-INTERMEDIATE-BASE (SIB) MARGIN SCORE INTERNATIONAL CONSORTIUM 18
IF A PELVIC LYMPH NODE DISSECTION AT RADICAL PROSTATECTOMY IS PLANNED, THIS MUST BE EXTENDED: RESULTS OF A SENSITIVITY ANALYSIS 17
Evaluation of the Prognostic Significance of Altered Mammalian Target of Rapamycin Pathway Biomarkers in Upper Tract Urothelial Carcinoma 17
PROGNOSTIC VALUE OF PD-1 AND PD-L1 EXPRESSION IN PATIENTS WITH HIGH-GRADE UROTHELIAL CARCINOMA OF THE UPPER URINARY TRACT 17
Impact of 3D conformal therapy on toxicity and clinical outcome in a single-institution series of 390 patients treated with adjuvant or salvage after radical prostatectomy 17
IMPACT OF THE INVASION OF PERINEPHRIC OR RENAL SINUS FAT IN PATIENTS WITH RENAL CELL CARCINOMA AND VENOUS TUMOR THROMBUS 17
Totale 10.094
Categoria #
all - tutte 47.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.490


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022331 0 67 35 17 3 12 24 21 17 32 27 76
2022/2023489 68 81 25 35 38 105 13 40 57 2 20 5
2023/2024338 14 19 11 36 53 81 42 8 28 7 1 38
2024/20251.727 66 179 58 41 83 30 186 54 214 262 227 327
2025/20266.569 423 251 316 534 518 214 687 164 315 351 378 2.418
2026/20271.403 636 767 0 0 0 0 0 0 0 0 0 0
Totale 12.260